These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 29168185)
101. The YY1/miR-548t-5p/CXCL11 signaling axis regulates cell proliferation and metastasis in human pancreatic cancer. Ge WL; Chen Q; Meng LD; Huang XM; Shi GD; Zong QQ; Shen P; Lu YC; Zhang YH; Miao Y; Zhang JJ; Jiang KR Cell Death Dis; 2020 Apr; 11(4):294. PubMed ID: 32341359 [TBL] [Abstract][Full Text] [Related]
102. ZCCHC10 suppresses lung cancer progression and cisplatin resistance by attenuating MDM2-mediated p53 ubiquitination and degradation. Ning Y; Hui N; Qing B; Zhuo Y; Sun W; Du Y; Liu S; Liu K; Zhou J Cell Death Dis; 2019 May; 10(6):414. PubMed ID: 31138778 [TBL] [Abstract][Full Text] [Related]
103. PYK2 Is Involved in Premalignant Acinar Cell Reprogramming and Pancreatic Ductal Adenocarcinoma Maintenance by Phosphorylating β-Catenin Gao C; Chen G; Zhang DH; Zhang J; Kuan SF; Hu W; Esni F; Gao X; Guan JL; Chu E; Hu J Cell Mol Gastroenterol Hepatol; 2019; 8(4):561-578. PubMed ID: 31330317 [TBL] [Abstract][Full Text] [Related]
104. MicroRNA-448 suppresses metastasis of pancreatic ductal adenocarcinoma through targeting JAK1/STAT3 pathway. Yu DL; Zhang T; Wu K; Li Y; Wang J; Chen J; Li XQ; Peng XG; Wang JN; Tan LG Oncol Rep; 2017 Aug; 38(2):1075-1082. PubMed ID: 28677798 [TBL] [Abstract][Full Text] [Related]
105. KLF11 promotes the proliferation of breast cancer cells by inhibiting p53-MDM2 signaling. Hou ZH; Tao M; Dong J; Qiu HM; Li F; Bai XY Cell Signal; 2024 Aug; 120():111238. PubMed ID: 38810862 [TBL] [Abstract][Full Text] [Related]
106. Increased SPRY1 expression activates NF-κB signaling and promotes pancreatic cancer progression by recruiting neutrophils and macrophages through CXCL12-CXCR4 axis. Shi T; Li X; Zheng J; Duan Z; Ooi YY; Gao Y; Wang Q; Yang J; Wang L; Yao L Cell Oncol (Dordr); 2023 Aug; 46(4):969-985. PubMed ID: 37014552 [TBL] [Abstract][Full Text] [Related]
107. ZC3HAV1 promotes the proliferation and metastasis via regulating KRAS in pancreatic cancer. Huang W; Hua H; Xiao G; Yang X; Yang Q; Jin L Aging (Albany NY); 2021 Jul; 13(14):18482-18497. PubMed ID: 34319912 [TBL] [Abstract][Full Text] [Related]
108. LincRNA-p21 knockdown reversed tumor-associated macrophages function by promoting MDM2 to antagonize* p53 activation and alleviate breast cancer development. Zhou L; Tian Y; Guo F; Yu B; Li J; Xu H; Su Z Cancer Immunol Immunother; 2020 May; 69(5):835-846. PubMed ID: 32062693 [TBL] [Abstract][Full Text] [Related]
109. ESF1 positively regulates MDM2 and promotes tumorigenesis. Zhang P; Sun C; Yin T; Guo J; Chong D; Tang Y; Liu Y; Li Y; Gu Y; Lu L Int J Biol Macromol; 2024 Sep; 276(Pt 1):133652. PubMed ID: 38971273 [TBL] [Abstract][Full Text] [Related]
110. Human pan-cancer analysis of the predictive biomarker for the CDKN3. Chen Y; Li D; Sha K; Zhang X; Liu T Eur J Med Res; 2024 May; 29(1):272. PubMed ID: 38720365 [TBL] [Abstract][Full Text] [Related]
111. Activation of the YY1-UGT2B7 Axis Promotes Mammary Estrogen Homeostasis Dysregulation and Exacerbates Breast Tumor Metastasis. Xu J; Zhou Y; He S; Wang Y; Ma J; Li C; Liu Z; Zhou X Drug Metab Dispos; 2024 Apr; 52(5):408-421. PubMed ID: 38575184 [TBL] [Abstract][Full Text] [Related]
112. N-cadherin and keratinocyte growth factor receptor mediate the functional interplay between Ki-RASG12V and p53V143A in promoting pancreatic cell migration, invasion, and tissue architecture disruption. Deramaudt TB; Takaoka M; Upadhyay R; Bowser MJ; Porter J; Lee A; Rhoades B; Johnstone CN; Weissleder R; Hingorani SR; Mahmood U; Rustgi AK Mol Cell Biol; 2006 Jun; 26(11):4185-200. PubMed ID: 16705170 [TBL] [Abstract][Full Text] [Related]
113. YY1 directly suppresses MYCT1 leading to laryngeal tumorigenesis and progress. Qu SY; Sun YY; Li YH; Xu ZM; Fu WN Cancer Med; 2017 Jun; 6(6):1389-1398. PubMed ID: 28485541 [TBL] [Abstract][Full Text] [Related]
114. Epigenetic silencing Du Q; Zhang M; Gao A; He T; Guo M Cancer Biol Ther; 2024 Dec; 25(1):2302924. PubMed ID: 38226836 [TBL] [Abstract][Full Text] [Related]
116. The transcription factor PBX3 promotes tumor cell growth through transcriptional suppression of the tumor suppressor p53. Li WF; Herkilini A; Tang Y; Huang P; Song GB; Miyagishi M; Kasim V; Wu SR Acta Pharmacol Sin; 2021 Nov; 42(11):1888-1899. PubMed ID: 33526870 [TBL] [Abstract][Full Text] [Related]
117. Genomic alterations link Rho family of GTPases to the highly invasive phenotype of pancreas cancer. Kimmelman AC; Hezel AF; Aguirre AJ; Zheng H; Paik JH; Ying H; Chu GC; Zhang JX; Sahin E; Yeo G; Ponugoti A; Nabioullin R; Deroo S; Yang S; Wang X; McGrath JP; Protopopova M; Ivanova E; Zhang J; Feng B; Tsao MS; Redston M; Protopopov A; Xiao Y; Futreal PA; Hahn WC; Klimstra DS; Chin L; DePinho RA Proc Natl Acad Sci U S A; 2008 Dec; 105(49):19372-7. PubMed ID: 19050074 [TBL] [Abstract][Full Text] [Related]
118. NFAT activation by FKBP52 promotes cancer cell proliferation by suppressing p53. Hanaki S; Habara M; Tomiyasu H; Sato Y; Miki Y; Masaki T; Shibutani S; Shimada M Life Sci Alliance; 2024 Aug; 7(8):. PubMed ID: 38803221 [TBL] [Abstract][Full Text] [Related]
119. Risk SNP in a transcript of RP11-638I2.4 increases lncRNA-YY1 interaction and pancreatic cancer susceptibility. Zhang M; Li Y; Zhang F; Geng H; Cai Y; Lu Z; Li B; Ning C; Wang W; Li H; Tian J; Zhu Y; Miao X Arch Toxicol; 2023 Oct; 97(10):2799-2812. PubMed ID: 37587385 [TBL] [Abstract][Full Text] [Related]
120. The role of USP7-YY1 interaction in promoting colorectal cancer growth and metastasis. Shao ZY; Yang WD; Qiu H; He ZH; Lu MR; Shen Q; Ding J; Zheng JN; Bai J Cell Death Dis; 2024 May; 15(5):347. PubMed ID: 38769122 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]